Evaluating the validity of responsiveness to inhaled nitric oxide in pediatric patients with ARDS: An analytic tool

Chest

Volumn 119, Issue 4, 2001, Pages 1166-1172

  Baldauf, M ^a   Silver, P ^a   Sagy, M ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

ARDS; Criteria; Nitric oxide; Pulmonary hypertension; Responsiveness

Indexed keywords

NITRIC OXIDE; VASOACTIVE AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; OXYGEN BREATHING; OXYGEN TENSION; OXYGENATION; PEDIATRICS; PH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT OUTCOME; VALIDATION PROCESS; VENTILATOR;

EID: 0034913591     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.4.1166     Document Type: Article

References (48)

1. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
2. Inhaled nitric oxide selectively reverses human hypoxic vasoconstriction without causing systemic vasodilation
3. Inhaled nitric oxide for the adult respiratory distress syndrome
4. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure
5. Nitric oxide and the lung (NHLBI Workshop Summary)
6. Effectiveness of nitric oxide inhalation in septic ARDS
7. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
8. Sample size requirement in cohort and case-control studies of disease
9. Introduction to sample size determination and power analysis for clinical trials
10. Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial
11. Extracorporeal membrane oxygenation in pediatric respiratory failure
12. 2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension
13. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnea in patients with acute respiratory distress syndrome
14. Impact of respiratory acid-base status in patients with pulmonary hypertension
15. The prone position improves arterial oxygenation and reduces shunt in oleic-acid-induced acute lung injury
16. Effect of prone and supine positions on functional residual capacity, oxygenation and respiratory mechanics in ventilated infants and children
17. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome
18. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome
19. Reduction of lung perfusion increases VA/Q heterogeneity
20. Effects of inspired carbon dioxide on ventilation-perfusion matching in normoxia, hypoxia, and hyperoxia
21. Inhaled nitric oxide versus conventional therapy: Effect on oxygenation in ARDS
22. Additive effect of gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome
23. Efficacy if inhaled nitric oxide in patients with severe ARDS
24. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome
25. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide
26. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
27. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction in sheep
28. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: Dose response, prolonged inhalation and weaning
29. Early response to inhaled nitric oxide and its relationship to outcome in children with severe hypoxemic respiratory failure
30. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn
31. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure
32. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
33. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn
34. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study
35. Inhaled nitric oxide in congenital heart disease
36. Inhaled nitric oxide as therapy for pulmonary hypertension after operations for congenital heart defects
37. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery
38. Is nitric oxide inhalation a "cosmetic" therapy in acute respiratory distress syndrome?
39. Just say NO to inhaled nitric oxide for the adult respiratory distress syndrome
40. Nitric oxide inhalation in acute respiratory distress syndrome: It works, but can we prove it?
41. National survey of diagnosis and management of persistent pulmonary hypertension of the newborn
42. Mechanisms of hypoxic pulmonary vasoconstriction
43. Pulmonary microthrombosis in severe adult respiratory distress syndrome
44. Cardiopulmonary interactions in acute lung injury: Clinical and prognostic importance of pulmonary hypertension
45. Influence of positive end-expiratory pressure on left ventricular performance
46. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome
47. Persistent pulmonary hypertension in the neonate: Diagnosis and management
48. Persistent pulmonary hypertension of the newborn